feed,title,long_url,short_url
Benzinga,Kodiak Sciences' KSI-301 Shows Durable Benefit In Retinal Disease Settings,https://www.benzinga.com/general/biotech/21/02/19667970/kodiak-sciences-ksi-301-shows-durable-benefit-in-retinal-disease-settings,https://j.mp/3k0coP9
